Why bleeding can get worse before it stops – and exactly what to do about it

The Symptom Nobody Warned You About

Most women are prepared, at least in theory, for their periods to become irregular as they approach menopause. What almost nobody prepares them for is that those periods might become heavier – sometimes dramatically so. Flooding that saturates a pad in under an hour. Clots the size of a fifty-pence coin. Periods lasting nine, ten, eleven days. Fatigue so severe that functioning normally becomes a daily challenge.

This is one of the most prevalent and most distressing symptoms of perimenopause – and one of the least discussed. More than 3 out of 4 women (78%) between the ages of 40–54 report experiencing heavy menstrual bleeding within a six-month window, and 90% say they’ve had periods that have lasted more than they expected during perimenopause.

Heavy periods in perimenopause are not simply an inconvenience. They are a physiological signal that something significant is happening hormonally – and in some cases, a clinical sign that something else requires investigation. Understanding the difference is the most important thing this article can help you do.

Part 1: Why Perimenopause Makes Periods Heavier

The Hormonal Mechanism: Estrogen Without Its Counterbalance

In the normal reproductive cycle, estrogen and progesterone work as a balanced pair. Estrogen builds the endometrial lining (the uterine lining) through the first half of the cycle. After ovulation, progesterone steps in to stabilize and prepare that lining for a potential pregnancy – and if pregnancy does not occur, the coordinated fall of both hormones triggers a predictable, controlled menstrual bleed.

The key word is ovulation. Progesterone is only produced after an egg is released. And in perimenopause, ovulation becomes increasingly unreliable.

Anovulatory bleeding is a type of abnormal uterine bleeding that occurs when ovulation fails to occur during the menstrual cycle. Without ovulation, progesterone is not produced, resulting in unopposed estrogen stimulation of the endometrial lining. This process leads to irregular, unpredictable, and often heavy or prolonged menstrual bleeding.

Without enough progesterone to counterbalance estrogen, the endometrial lining builds up more than usual during perimenopause. This can lead to heavier bleeding when it sheds, and sometimes heavy menstruation with large clots.

The paradox – and the source of so much confusion for women – is that perimenopause involves declining estrogen overall, but the transition is not a smooth decline. It is characterised by wild fluctuations: estrogen can surge dramatically in some cycles, particularly in early perimenopause, before the eventual decline. Perimenopausal women menstruate, but they have a high rate of anovulatory cycles and cycles with delayed ovulation and shortened luteal phases, thus the balance between estrogen and progesterone is shifted towards estrogen. Clinically, high estrogen levels present as heavy menstrual flow, tender and swollen breasts, or increased migraine headaches.

This estrogen-dominant state – not estrogen deficiency – is what drives heavy perimenopausal bleeding. It is precisely why the hormonal picture of perimenopause is so much more complex than the simpler story of postmenopause.

What the Excess Estrogen Does to the Uterine Lining

The persistence of proliferative endometrium, which becomes unstable and is prone to irregular, heavy shedding, combined with high estrogen levels unopposed by progesterone, contributes to increased vascular fragility and decreased vascular tone in the endometrium, resulting in an increased volume of bleeding.

In plain terms: without progesterone’s stabilising effect, the uterine lining continues to build up rather than differentiating into the secretory phase of a normal cycle. When it finally sheds – triggered by the eventual drop in estrogen – it does so incompletely, erratically, and in larger volumes. Hence the flooding, the clots, and the prolonged duration.

The Cycle Changes That Accompany Heavy Bleeding

During the perimenopausal period, the earliest menstrual change commonly involves shortening of the follicular phase, which leads to more frequent menses. Subsequent progression usually produces longer menstrual cycles. Many cycles become anovulatory, resulting in perimenopausal abnormal uterine bleeding.

This explains why many women in their early to mid-40s notice their cycles becoming shorter first – periods arriving every 21–24 days instead of every 28 – before later becoming longer and increasingly unpredictable. Both patterns reflect the same underlying hormonal disruption.

Part 2: What “Heavy” Actually Means – Clinical Definitions

The clinical definition of heavy menstrual bleeding (HMB) is measurable and specific: blood loss exceeding 80 mL per cycle. Practically, this translates to:

• Needing to change a pad or tampon more frequently than every two hours
• Bleeding for longer than seven days
• Passing clots larger than approximately 2.5 cm (a 50p coin or US quarter)
• “Flooding” – soaking through clothing or bedding
• Needing to use both a pad and a tampon simultaneously

Average menstrual blood loss varies between 30 and 40 mL per cycle, the upper limit being 60 to 80 mL per cycle. Menorrhagia is heavy cyclical bleeding that occurs when menstrual blood loss exceeds 80 mL per cycle. It is the most common gynecologic complaint, and normal menstrual loss increases with age, especially in perimenopausal women.

However, the subjective experience – what feels heavy or disruptive to you – is clinically relevant regardless of whether it meets the technical threshold. Any change in your usual pattern that significantly affects your daily life warrants clinical evaluation.

Part 3: The Consequences of Untreated Heavy Bleeding

Iron Deficiency and Anemia – The Hidden Drain

This is the most common and most frequently missed consequence of heavy perimenopausal bleeding – and it explains many of the symptoms women attribute to menopause itself.

Heavy menstrual bleeding is the most common cause of iron deficiency anemia among women of reproductive age in developed countries. A survey conducted among European women aged 18–57 revealed that 63% of women suffering from heavy menstrual bleeding were diagnosed with iron deficiency anemia. Research has reported that 86.3% of women suffering from heavy menstrual bleeding were found to have abnormally low levels of ferritin.

The symptoms of iron deficiency anemia – fatigue, brain fog, difficulty concentrating, palpitations, breathlessness, pallor, cold intolerance, and hair loss – are almost perfectly identical to the symptoms commonly attributed to perimenopause itself. Many women in this transition are living with significant iron deficiency that is never tested, never identified, and never treated, while their symptoms are attributed entirely to hormones.

Iron deficiency can also worsen the bleeding itself – iron is needed for platelet function, and its depletion further compromises the blood’s ability to clot and control menstrual flow.

The practical implication: if you are experiencing heavy periods in perimenopause and have not had a full blood count and serum ferritin tested recently, this is the most important investigation to request. A serum ferritin below 30 ng/mL is associated with impaired function; below 15 ng/mL constitutes frank deficiency.

Quality of Life Impact

Heavy perimenopausal bleeding affects not just physical health but work performance, social life, sleep, sexual intimacy, and psychological wellbeing. Women describe planning social events around their cycle, avoiding travel, missing work, and living in constant anxiety about flooding incidents. This is not a minor inconvenience – it is a clinical symptom that merits clinical management.

Part 4: When to See a Doctor – The Red Flags That Cannot Wait

Most heavy periods in perimenopause have a hormonal explanation. But some require urgent clinical investigation to rule out conditions that are neither normal nor self-limiting.

See your doctor promptly if you experience:

Flooding or soaking through protection more than once per hour for several hours – this constitutes acute heavy bleeding that may require immediate assessment and treatment.

Bleeding between periods (intermenstrual bleeding) – spotting or bleeding outside of a period, regardless of how light, is never simply a perimenopause symptom and always warrants investigation.

Bleeding after sex (postcoital bleeding) – always requires gynecological assessment, as it can indicate cervical pathology.

Any bleeding after 12 consecutive months without a period – postmenopausal bleeding is not normal. It is a red flag symptom requiring urgent endometrial assessment to exclude endometrial cancer.

Periods becoming heavier and more frequent simultaneously – a pattern of progressively worsening, shortening, and heavier cycles can indicate fibroids, adenomyosis, or endometrial hyperplasia.

Associated symptoms of severe anemia – extreme fatigue, breathlessness at rest, palpitations, or fainting require urgent hematological assessment.

In perimenopausal women, the most common reported causes of heavy menstrual bleeding requiring investigation include endometrial hyperplasia and carcinoma, in addition to the more common structural causes – fibroids, adenomyosis, and endometrial polyps – seen across the reproductive years.

The clinician will typically request a transvaginal ultrasound (to assess the endometrium and exclude structural abnormalities) and an endometrial biopsy where indicated. These investigations are not alarming – they are routine, protective, and the responsible clinical response to significant perimenopausal bleeding.

Part 5: The Medical Treatment Options

The Levonorgestrel-Releasing Intrauterine System (Mirena / LNG-IUS)

The LNG-IUS is the most evidence-supported medical treatment for heavy perimenopausal bleeding and is recommended as a first-line option by multiple international gynecological societies. It delivers a low dose of progestogen locally to the uterine lining, suppressing endometrial proliferation and dramatically reducing or eliminating bleeding.

The LNG-IUS compared to combined oral contraceptive pills is associated with a greater reduction in heavy menstrual bleeding and a larger improvement in quality of life. In comparison with oral tranexamic acid, the LNG-IUS is proven superior in the treatment of heavy menstrual bleeding. Besides significantly reducing heavy menstrual bleeding, the LNG-IUS provides a highly effective method of contraception, to which exogenous estrogen supplementation can be added to relieve vasomotor symptoms.

This last point is clinically important: a woman with both heavy bleeding and vasomotor symptoms (hot flushes, night sweats) can have an LNG-IUS fitted to control the bleeding while taking systemic estrogen for symptom relief – providing a highly tailored hormonal combination without the endometrial risks of unopposed estrogen.

Oral Progesterone / Progestogen

Cyclic oral progestogen – typically medroxyprogesterone acetate or norethisterone, taken from days 15–25 of the cycle – addresses the core hormonal cause: it provides the progesterone that anovulatory cycles fail to produce, stabilizing and ultimately shedding the endometrial lining in a controlled manner.

Oral micronized progesterone (OMP) – the bioidentical form – is increasingly preferred. It produces fewer androgenic and glucocorticoid side effects than synthetic progestins and, because it is metabolised to allopregnanolone in the brain, has the additional benefit of supporting sleep and reducing anxiety – two concurrent concerns for many perimenopausal women.

Tranexamic Acid

Tranexamic acid is a non-hormonal, non-contraceptive medication that reduces heavy bleeding by inhibiting the breakdown of blood clots within the uterus. It only needs to be taken at the beginning of the menses for three to five days, when there is a heavy flow. It is taken only during the bleed – not continuously – and has no systemic hormonal effects. It is particularly useful for women who need rapid symptom relief while awaiting investigation results or hormonal treatment to take effect.

Combined Oral Contraceptives (COC)

Low-dose combined oral contraceptive pills regulate the cycle, suppress ovulation, and substantially reduce menstrual blood loss. Evidence shows a 12–77% success rate with COC for heavy menstrual bleeding compared to 3% with placebo. COCs for regulation of the menstrual cycle can be prescribed in healthy perimenopausal women with no contraindications. They also provide contraception – important, as perimenopause is not a reliable natural contraceptive state – and relieve other perimenopausal symptoms including hot flushes and breast tenderness.

NSAIDs (Anti-inflammatory Pain Relief)

Non-steroidal anti-inflammatory drugs such as ibuprofen or mefenamic acid, taken during menstruation, reduce prostaglandin production in the uterine lining – prostaglandins contribute to both blood vessel dilation and the volume of menstrual flow. They produce a modest reduction in blood loss (approximately 20–30%) and are useful for women with mild to moderate heavy bleeding and associated dysmenorrhea (period pain). They are not adequate as monotherapy for severe heavy bleeding but provide useful adjunctive relief.

Surgical Options

For women in whom medical management has failed or is contraindicated, several surgical options exist:

Endometrial ablation – destruction of the endometrial lining using heat, cold, microwave, or radiofrequency energy. It significantly reduces or eliminates bleeding in the majority of women. It is not appropriate for women who wish to preserve fertility and, because it is a perimenopause-specific intervention, it is typically offered to women whose family is complete. It does not protect against endometrial cancer in the small proportion of remaining endometrium that may be inaccessible to the ablation – ongoing gynecological monitoring continues to be important.

Hysterectomy – removal of the uterus, the only definitive cure for heavy menstrual bleeding. It is reserved for women who have not responded to, or cannot use, other treatments, and those with significant associated pathology (large fibroids, adenomyosis). It is a major surgical procedure with a recovery period of 6–8 weeks and is increasingly performed laparoscopically, reducing hospital stay.

Part 6: Nutrition and Lifestyle – Supporting Your Body Through Heavy Bleeding

Iron Repletion – The Non-Negotiable Priority

If heavy perimenopausal bleeding has been present for more than a few cycles, iron repletion should be treated as a clinical priority, not an afterthought.

Dietary iron: The most bioavailable sources are haem iron from animal foods – red meat (beef, lamb), organ meat (liver provides the most concentrated iron available), mussels, sardines, and dark poultry meat. Non-haem iron from plant sources (spinach, lentils, chickpeas, tofu, pumpkin seeds) is absorbed at approximately 2–20% compared to 15–35% for haem iron, but absorption is significantly enhanced by consuming them alongside vitamin C.

Avoid concurrent iron inhibitors: Coffee, tea, and calcium-rich foods consumed within an hour of iron-rich meals substantially reduce iron absorption. A practical strategy is to reserve your iron-rich meal for a time when you are not having coffee or dairy alongside it.

Supplemental iron: For women with confirmed iron deficiency (ferritin below 30 ng/mL) or anemia, dietary iron alone is unlikely to restore levels in a clinically meaningful timeframe. Oral iron supplementation – ferrous sulphate or ferrous gluconate, 200 mg daily or every other day (alternate-day dosing reduces gastrointestinal side effects while maintaining efficacy) – is the standard recommendation. If oral iron is poorly tolerated or absorption is inadequate, intravenous iron – now available as a single outpatient infusion – provides rapid restoration of iron stores.

Anti-Inflammatory Nutrition

Natural dietary support for heavy perimenopausal bleeding includes omega-3 fatty acids, magnesium, and specific dietary patterns that reduce systemic inflammation and support hormonal balance.

Omega-3 fatty acids (EPA and DHA from oily fish, or algae-based supplements) reduce prostaglandin production in the uterine lining – the same mechanism as NSAIDs, but through dietary means. Clinical studies have demonstrated reduction in menstrual blood loss with regular omega-3 supplementation.

Magnesium supports uterine muscle relaxation and prostaglandin regulation. It is frequently deficient in perimenopausal women. Sources include dark leafy greens, pumpkin seeds, dark chocolate, almonds, and legumes. Supplemental magnesium glycinate (300–400 mg daily) is well-tolerated and evidence-supported.

Vitamin C – beyond enhancing iron absorption, vitamin C supports capillary wall integrity in the endometrium, potentially reducing vascular fragility and blood loss volume. 500–1,000 mg daily alongside iron supplementation is a practical and safe combination.

Reducing refined sugar and ultra-processed foods – both promote insulin resistance and systemic inflammation that can worsen hormonal imbalance and endometrial instability. The dietary pattern with the strongest overall evidence for hormone balance and reduced inflammation is the Mediterranean diet: abundant vegetables, legumes, whole grains, oily fish, olive oil, and nuts, with minimal processed foods.

Stress and Cortisol Management

Chronic psychological stress elevates cortisol, which disrupts the HPO axis (hypothalamic-pituitary-ovarian axis) and further suppresses the already-unreliable ovulation of perimenopause. Less ovulation means less progesterone means more unopposed estrogen means heavier bleeding. Stress is not a distant indirect contributor – it is part of the same hormonal cascade. Consistent sleep, regular aerobic exercise, and evidence-based stress reduction (mindfulness, yoga, social connection) are not peripheral lifestyle suggestions in this context; they are part of managing the hormonal environment that drives heavy bleeding.

Part 7: The Practical Action Plan

Step 1: Track your cycle and bleeding accurately. Apps such as Clue or Natural Cycles allow you to log cycle length, flow, clot size, and pad/tampon usage – information that is clinically invaluable and that most women do not bring to appointments because they do not realize it matters.

Step 2: Test comprehensively. Request a full blood count (FBC), serum ferritin, thyroid function (TSH), and – if your clinician deems appropriate based on your history – a transvaginal ultrasound. Do not accept “it’s perimenopause” as the complete explanation without ruling out anemia, thyroid disease, and structural causes.

Step 3: Start iron repletion if ferritin is below 30 ng/mL. This is a practical step you can take immediately.

Step 4: Discuss medical options with your GP or gynecologist. The LNG-IUS, oral progesterone, tranexamic acid, and combined contraceptives each suit different clinical profiles – your clinician can help identify the most appropriate option based on your symptoms, medical history, and whether contraception is relevant.

Step 5: Prioritize the dietary foundations – iron-rich foods, omega-3s, magnesium, and reduced ultra-processed food – alongside any medical treatment. These are not alternatives to medical treatment; they are the nutritional infrastructure that supports recovery.

Step 6: Do not wait for things to improve on their own if they are significantly affecting your life. Heavy perimenopausal bleeding is not inevitable, it is not untreatable, and it is not something to be endured in silence.

The Conclusion

Heavy periods during perimenopause are among the most universal and least expected symptoms of this transition. They are rooted in a clear, well-understood biological mechanism – anovulatory cycles producing unopposed estrogen and an unstable, thickened endometrial lining – and they have a comprehensive range of evidence-based medical and nutritional treatments.

The risks of leaving them untreated are real: iron deficiency anemia that saps energy, cognition, and cardiac function; endometrial hyperplasia from chronic unopposed estrogen; and the possibility of missing a structural or oncological cause in a small but important minority of cases.

You deserve a clinician who takes your bleeding seriously, investigates it appropriately, and offers you the full range of management options. Heavy periods are not a rite of passage. They are a clinical symptom. And they are eminently, evidence-based addressable.

For more useful articles and expert guidance, explore the Womeno app – your personal digital companion through the hormonal transition. Download the app HERE

Sources

1. Jones K, Sung S. Anovulatory Bleeding. StatPearls Publishing. Updated March 23, 2025. NCBI Bookshelf NBK549773.
2. Peacock K, Carlson K, Ketvertis KM. Menopause. StatPearls Publishing. Updated March 23, 2026. NCBI Bookshelf NBK507826.
3. Dr. Brighten. Heavy Periods in Perimenopause: Causes, Clots, and How to Stop Heavy Bleeding.drbrighten.com. August 2025.
4. Natural Cycles. Perimenopause and Long Periods: What’s Normal and How to Cope? naturalcycles.com. October 2025. (Citing: NHS. Heavy periods. nhs.uk. January 2025)
5. Biote. Decoding Perimenopause Part II: Strategies for Irregular Bleeding. biote.com. December 2023.
6. Rees M et al. Perimenopausal abnormal uterine bleeding. Maturitas. 2024. doi:10.1016/j.maturitas.2024.000392
7. Santer M et al. Managing Menorrhagia. US Pharmacist. 2011. uspharmacist.com
8. American College of Obstetricians and Gynecologists (ACOG). Heavy Menstrual Bleeding. acog.org. Updated 2024.
9. Main Line Health / Kwan M MD. Get help for abnormal perimenopausal bleeding. mainlinehealth.org. 2019. (Cited for LNG-IUS and tranexamic acid evidence)
10. Cheung KL, Yuet Ping Mun S. A scoping review on heavy menstrual bleeding and anaemia: A less explored phenomenon. PMC12975095. 2025.
11. Akpan IJ et al. Iron deficiency anaemia in patients with heavy menstrual bleeding: The patients’ perspective from diagnosis to treatment. Women’s Health (Lond). PMC11869313. 2025. doi:10.1177/17455057251321221
12. Franik S et al. A Review of Clinical Guidelines on the Management of Iron Deficiency and Iron-Deficiency Anaemia in Women with Heavy Menstrual Bleeding. PMC7695235. 2020.
13. Healthline. Risk of Anaemia with Uterine Fibroids. healthline.com. February 2026.
14. Dr. Whelan. Anemia in Perimenopause. drwhelan.com. August 2024.
15. ClinicalTrials.gov NCT01464697. Progesterone for Perimenopausal Night Sweats. Protocol document citing estrogen dominance and heavy menstrual flow in perimenopause.
16. WHO. Accelerating anemia reduction: A complex framework for action. Geneva: World Health Organization. 2023. (Recognising HMB as a risk factor for anaemia)